China News Agency, Manila, March 13. According to the Philippine News Agency, the Philippine Food and Drug Administration (FDA) has granted China's Sinovac CoronaVac emergency use authorization for the use of the vaccine in the Philippines for children aged 6 and above. Human vaccination.
On March 13, Enrique Gonzales, chairman of the Philippine IP Biotech Group (IP Biotech Group), issued a statement saying that the Philippine Food and Drug Administration signed the relevant emergency use authorization on the 12th. The eight-page document was signed by the FDA's director general, Dr. Oscar Gutierrez Jr.
Gonzalez said the Philippine government "allows Filipino minors to be vaccinated against Sinovac, which will help protect the younger generation in the Philippines and consolidate the country's efforts to control the epidemic, while also ensuring equal access to vaccine protection for Filipinos."
Gonzalez introduced Chile's research data and said that the Sinovac vaccine was 74% effective among the 1.9 million Chilean minors aged 6 to 17 who were vaccinated with Sinovac.
It prevented the hospitalization of 90 percent of minors who received the vaccine but still had breakthrough infections, and prevented 100 percent of those hospitalized from being admitted to intensive care units and dying.
"The data show that the Sinovac vaccine is indeed a very safe option for children and adolescents."
He introduced that countries such as Indonesia, Malaysia and China are using Sinovac vaccines for minor vaccinations.
Gonzalez said the introduction of the Sinovac vaccine as part of the juvenile vaccination program will help the Philippines achieve its goal of vaccinating 39 million juveniles.
(over)